Capricorn Fund Managers »

Taysha Gene Therapies shares owned by Capricorn Fund Managers

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Capricorn Fund Managers from 13F filings

Historical chart of Capricorn Fund Managers investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Capricorn Fund Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Capricorn Fund Managers

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 300k 5.50

More positions owned by Capricorn Fund Managers

Zymeworks Del (ZYME)
Waystar Holding Corp (WAY)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvation Bio Com Cl A (NUVB)
Microsoft Corporation (MSFT)
Guardant Health (GH)
Amazon (AMZN)
Karooooo Ord Shs (KARO)
EXACT Sciences Corporation (EXAS)
Alphabet Inc - Class A Cap Stk Cl A (GOOGL)
Roivant Sciences SHS (ROIV)
BioLife Solutions Com New (BLFS)
Astera Labs (ALAB)
Visa Com Cl A (V)
Sotera Health (SHC)

View all positions for Capricorn Fund Managers

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies